Carolyn M. Nielsen
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.
Journal: Frontiers in immunology
Published: November 10, 2025
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Journal: Nature communications
Published: June 20, 2025
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.
Journal: The Lancet. Infectious diseases
Published: November 08, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Journal: The Lancet. Infectious diseases
Published: March 25, 2024
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Journal: Cell
Published: September 28, 2023
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Journal: Science translational medicine
Published: July 12, 2023
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Journal: Med (New York, N.Y.)
Published: April 14, 2023
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Journal: Frontiers in immunology
Published: March 24, 2023
Human lymphoid tissue sampling for vaccinology.
Journal: Frontiers in immunology
Published: September 15, 2022
Last Updated: 09/26/2026